What is Neurocysticercosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Neurocysticercosis is a major cause of seizure and neurologic disease worldwide, caused by the larval form of the cestode parasite Taenia solium.

Definition and Causes

  • It is a type of cysticercosis that involves the central nervous system, including the brain parenchyma, ventricles, basilar cisterns, sulci, gyri, spine, and retina 1.
  • Humans can be hosts to both the tapeworm form and larval forms of the parasite, with the tapeworm form acquired by ingestion of undercooked pork 1.
  • The larval form, also known as cysticercosis, can be acquired by ingestion of ova, and neurocysticercosis refers to cysticercosis involving the central nervous system 1.

Clinical Manifestations

  • The main clinical manifestations of neurocysticercosis vary with the location of the cysticerci, and can include seizures, headache, obstructive hydrocephalus, communicating hydrocephalus, meningitis, stroke, and focal neurologic findings 1.
  • Parenchymal neurocysticercosis typically presents with seizures or headache, while ventricular neurocysticercosis most often presents with obstructive hydrocephalus 1.

Diagnosis

  • Diagnosis of neurocysticercosis involves a thorough history and physical examination, with particular attention to exposure to the parasite 1.
  • Neuroimaging, including computed tomography (CT) and magnetic resonance imaging (MRI), is also essential for diagnosis, with CT more sensitive for detecting calcified lesions and MRI more sensitive for detecting the scolex and edema 1.
  • The enzyme-linked immunotransfer blot (EITB) using parasite glycoproteins is the serologic antibody test of choice, with a sensitivity of close to 100% in patients with multiple parenchymal, ventricular, or subarachnoid neurocysticercosis 1.

From the Research

Definition and Overview of Neurocysticercosis

  • Neurocysticercosis (NCC) is the most common parasitic disease of the human central nervous system (CNS) 2.
  • It is a pleomorphic disease with a diverse array of clinical manifestations, dependent on factors such as the number and size of the cysticerci, their stage of development, and localization within the brain 2.
  • NCC is caused by the larval (cystic) form of the pork cestode tapeworm, Taenia solium 3.

Clinical Manifestations and Diagnosis

  • The clinical manifestations of NCC largely depend on the host immune response against the parasite 4.
  • Diagnosis is based on neuroimaging studies (computerized tomography, magnetic resonance imaging) and antibody/antigen detection in the serum and cerebrospinal fluid 4.
  • Valid screening tools, including immunological and molecular tests, are needed to reduce reliance on neuroimaging, which is not usually accessible in endemic areas 5.

Treatment and Prevention

  • Anticysticercal therapy has been marked by controversy, with randomized controlled trials yielding conflicting data 4.
  • WHO and Infectious Diseases Society of America/American Society of Tropical Medicine and Hygiene guidelines emphasize the importance of corticosteroids and antiparasitic drugs for viable parenchymal disease and single enhancing lesions 6.
  • Prevention strategies must rely on multiple approaches, tailoring each to the special features of the particular endemic area 4.
  • Field studies are demonstrating the feasibility of eradication using a combination of mass chemotherapy for human tapeworms and vaccination/treatment of porcine cysticercosis 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of neurocysticercosis.

Nature reviews. Neurology, 2011

Research

Neurocysticercosis.

Arquivos de neuro-psiquiatria, 2013

Research

Neurocysticercosis: the good, the bad, and the missing.

Expert review of neurotherapeutics, 2018

Research

Neurocysticercosis: an update on diagnosis, treatment, and prevention.

Current opinion in infectious diseases, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.